NDC 58198-0027-4 - Claro
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 58198-0027
- Requested NDC
- 58198-0027-4
- Package NDCs from labels
- 58198-0027-1, 58198-0027-2, 58198-0027-3, 58198-0027-4
- Manufacturer
- Elanco US Inc.
- Effective date
- 2025-07-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CLARO™ Elanco TM (florfenicol, terbinafine, mometasone furoate) | Elanco US Inc. | 2025-07-22 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58198-0027-1 | Claro | 1 mL in 1 TUBE, WITH APPLICATOR | SOLUTION | 1 | 6 | |
| 58198-0027-2 | Claro | 2 in 1 CARTON | SOLUTION | 2 | 6 | |
| 58198-0027-2 | Claro | 1 in 1 BLISTER PACK | SOLUTION | 1 | 6 | |
| 58198-0027-3 | Claro | 1 in 1 BLISTER PACK | SOLUTION | 1 | 6 | |
| 58198-0027-3 | Claro | 10 in 1 CARTON | SOLUTION | 10 | 6 | |
| 58198-0027-4 | Claro | 1 in 1 BLISTER PACK | SOLUTION | 1 | 6 | |
| 58198-0027-4 | Claro | 20 in 1 CARTON | SOLUTION | 20 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 58198-0027 | CLARO (FLORFENICOL, TERBINAFINE, MOMETASONE FUROATE) SOLUTION [ELANCO US INC.] | 5 | 7 package rows | 20231115_9bd1d059-68a6-459f-9f79-2fcd97c952d6.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mometasone Furoate | MOMETASONE FUROATE | Padagis Israel Pharmaceuticals Ltd | d986282f-da3c-43b6-a3f6-40886d4a1915 | 2026-08-27 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | Torrent Pharmaceuticals Limited | 18ef90de-f74d-492f-a125-49da1875bd29 | 2026-08-06 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | Preferred Pharmaceuticals Inc. | 831f7694-8153-4a79-a453-48020b26f035 | 2026-07-17 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | Preferred Pharmaceuticals Inc. | bfe3d098-a5f8-4e5d-9fa6-eac167bad3e9 | 2026-07-17 | Warnings, Adverse reactions | 04201GDN4R |
| Kimtara Nail Fungus Treatment | KIMTARA NAIL FUNGUS TREATMENT | GUANGZHOU YUSONG FINE CHEMICLS Co., Ltd | 5678e260-10c4-f203-e063-6294a90a6223 | 2026-07-13 | Warnings | G7RIW8S0XP |
| Dulera | MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE | Organon LLC | 8f399784-f257-4f31-b3dc-368bf2a1864d | 2026-07-10 | Warnings, Adverse reactions | 04201GDN4R |
| ASMANEX | MOMETASONE FUROATE | Organon LLC | 10b36fb2-6b0d-4f20-b197-3564d6f594b9 | 2026-07-07 | Warnings, Adverse reactions | 04201GDN4R |
| ASMANEX HFA | MOMETASONE FUROATE | Organon LLC | 0c6d63da-41bc-4894-bead-198e66c848ac | 2026-07-07 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | Bryant Ranch Prepack | 5eda1256-001a-4f40-b3ca-15349d532033 | 2026-05-21 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone furoate | MOMETASONE FUROATE | Encube Ethicals, Inc. | dae3eaea-fc17-48a2-ae30-2a68f7811bce | 2026-04-06 | Warnings, Adverse reactions | 04201GDN4R |
| Toenail Fungus Treatment | TERBINAFINE | Shenzhen Wankelai E-commerce Co., Ltd. | 4dc1d7f7-e4ae-c54b-e063-6394a90aa420 | 2026-03-24 | Warnings | G7RIW8S0XP |
| Mometasone Furoate | MOMETASONE FUROATE | Sportpharm LLC | f02dea3f-9e4f-4c5a-bea3-f428afca803b | 2026-03-19 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | Preferred Pharmaceuticals Inc. | ad47cceb-e471-48d6-85d6-e4a3f10e2ac6 | 2026-01-27 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | A-S Medication Solutions | 16e134c7-39fb-4d16-9c24-a6df438967bf | 2026-01-23 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | Bryant Ranch Prepack | c953bd40-8a52-4812-837a-baaf1b17b3aa | 2025-10-29 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | Bryant Ranch Prepack | 88f5622d-64da-42b7-8aa9-62a5da5ebfbb | 2025-10-24 | Warnings, Adverse reactions | 04201GDN4R |
| MOMETASONE FUROATE | MOMETASONE FUROATE | Encube Ethicals, Inc. | 1ebaac16-432e-4e92-9d58-718bd76ae368 | 2025-09-15 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | Bryant Ranch Prepack | 79e13e15-5bd3-48b1-877a-1cd92abbc7c5 | 2025-09-08 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | Bryant Ranch Prepack | 2f79063c-f7da-4e71-b054-d24b86dd386a | 2025-09-05 | Warnings, Adverse reactions | 04201GDN4R |
| Mometasone Furoate | MOMETASONE FUROATE | Padagis Israel Pharmaceuticals Ltd | a12fef6b-681e-4f80-8bcd-3f01733f1a67 | 2025-07-07 | Warnings, Adverse reactions | 04201GDN4R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.